Business Description
Anthera Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US03674U3005
Description
Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 0.59 | |||||
9-Day RSI | 6.4 | |||||
14-Day RSI | 15.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Yield % | -1065066.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ANTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anthera Pharmaceuticals Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.7 | ||
| Beta | -128.5929 | ||
| 3-Year Sharpe Ratio | 0.54 | ||
| 3-Year Sortino Ratio | 4.73 | ||
| Volatility % | 912.59 | ||
| 14-Day RSI | 15.98 | ||
| 14-Day ATR ($) | 0.000008 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.00001 - 0.001 | ||
| Shares Outstanding (Mil) | 26.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anthera Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anthera Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.125:1 Stock Split | 2017-05-01 | 2.64 (-8.33%) | ||
| 0.125:1 Stock Split | 2013-07-15 | 32.64 (+4.08%) |
Show
Entries
Anthera Pharmaceuticals Inc Frequently Asked Questions
What is Anthera Pharmaceuticals Inc(ANTH)'s stock price today?
The current price of ANTH is $0.00. The 52 week high of ANTH is $0.00 and 52 week low is $0.00.
When is next earnings date of Anthera Pharmaceuticals Inc(ANTH)?
The next earnings date of Anthera Pharmaceuticals Inc(ANTH) is .
Does Anthera Pharmaceuticals Inc(ANTH) pay dividends? If so, how much?
Anthera Pharmaceuticals Inc(ANTH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Anthera Pharmaceuticals Inc
No articles.